Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker

被引:12
|
作者
Sikka, K. [1 ]
Sharma, S. C. [1 ]
Thakar, A. [1 ]
Dattagupta, S. [2 ]
机构
[1] All India Inst Med Sci, Dept Otorhinolaryngol Head & Neck Surg, New Delhi 110029, India
[2] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India
来源
JOURNAL OF LARYNGOLOGY AND OTOLOGY | 2012年 / 126卷 / 05期
关键词
Cholesteatoma; Child; Cellular Proliferation; Pathology; MIDDLE-EAR CHOLESTEATOMA; NUCLEAR ANTIGEN; MEATAL SKIN; CELL; QUANTIFICATION; CHILDREN; MIB-1;
D O I
10.1017/S002221511100315X
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: The aggressiveness of cholesteatoma in children compared with adults is well known. However, the factors influencing the poorer prognosis of paediatric cholesteatoma are not well understood. This study compared the proliferative potential of paediatric cholesteatoma with that of adult cholesteatoma, using Ki-67 as a proliferation marker. Methods: A prospective study of 67 patients with aural cholesteatoma was performed. Thirty-eight adult and 29 paediatric cases were evaluated using clinical parameters including bone erosion, complications and extent of disease. A surgical specimen underwent histological evaluation and measurement of the proliferation index using Ki-67 labelling. Normal epithelium from a control group was also examined. Results: Cholesteatoma epithelium has a greater rate of proliferation than normal skin. There were however no statistical differences between the paediatric and adult cholesteatoma groups in terms of clinical behaviour or proliferation potential. Paediatric cholesteatoma was similar to adult cholesteatoma in terms of complications, bone erosion and disease spread. Conclusion: Cholesteatoma is a disorder of epithelial proliferation. Although postulated to be more aggressive in children than adults, this study found no clinicopathological differences between paediatric and adult cases.
引用
收藏
页码:460 / 463
页数:4
相关论文
共 50 条
  • [41] Characterization of Cytokines and Proliferation Marker Ki-67 in Chronic Rhinosinusitis with Recurring Nasal Polyps
    Viksne, Rudolfs
    Sumeraga, Gunta
    Pilmane, Mara
    ADVANCES IN RESPIRATORY MEDICINE, 2022, 90 (05) : 451 - 466
  • [42] The cell proliferation antigen Ki-67 organises heterochromatin
    Sobecki, Michal
    Mrouj, Karim
    Camasses, Alain
    Parisis, Nikolaos
    Nicolas, Emilien
    Lleres, David
    Gerbe, Francois
    Prieto, Susana
    Krasinska, Liliana
    David, Alexandre
    Eguren, Manuel
    Birling, Marie-Christine
    Urbach, Serge
    Hem, Sonia
    Dejardin, Jerome
    Malumbres, Marcos
    Jay, Philippe
    Dulic, Vjekoslav
    Lafontaine, Denis L. J.
    Feil, Robert
    Fisher, Daniel
    ELIFE, 2016, 5
  • [43] Rhabdomyosarcoma disease spread evaluation on CT scans: Association with primary tumor size and Ki-67 proliferation marker
    Soffer, Shelly
    Amitai, Marianne Michal
    Shimon, Orit
    Ohana, Orly
    Rozendorn, Noa
    Barshack, Iris
    Weitzen, Rony
    Klang, Eyal
    CLINICAL IMAGING, 2019, 56 : 41 - 46
  • [44] KI-67 - AN IMMUNOHISTOCHEMICAL ASSESSMENT OF COLONIC CELLULAR PROLIFERATION
    BARSOUM, G
    WINSLET, M
    KEIGHLEY, MRB
    GUT, 1990, 31 (10) : A1170 - A1170
  • [45] EFFECT OF EMBOLIZATION OF MENINGIOMA ON KI-67 PROLIFERATION INDEX
    PAULUS, W
    MEIXENSBERGER, J
    HOFMANN, E
    ROGGENDORF, W
    JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (09) : 876 - 877
  • [46] The value of the FDG-GaTate and proliferation marker (ki-67) in the assessment of neuroendocrine tumours (NETs)
    AS Fathinul Fikri
    JN Abdul
    S Ramdave
    R Syafik-Eid
    Cancer Imaging, 15 (Suppl 1)
  • [47] Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer
    Katharina Heusinger
    Sebastian M. Jud
    Lothar Häberle
    Carolin C. Hack
    Peter A. Fasching
    Martina Meier-Meitinger
    Michael P. Lux
    Carsten Hagenbeck
    Christian R. Loehberg
    Thomas Wittenberg
    Claudia Rauh
    Florian Wagner
    Michael Uder
    Arndt Hartmann
    Rüdiger Schulz-Wendtland
    Matthias W. Beckmann
    David L. Wachter
    Breast Cancer Research and Treatment, 2012, 135 : 885 - 892
  • [48] Detection of mutations in the cDNA of the proliferation marker Ki-67 protein in four tumor cell lines
    Bubán, T
    Schmidt, M
    Broll, R
    Antal-Szalmás, P
    Duchrow, M
    CANCER GENETICS AND CYTOGENETICS, 2004, 149 (01) : 81 - 84
  • [49] KI-67 Proliferation Index is a Better Prognostic Marker Than Mitotic Count in Neuroendocrine Tumors
    Khan, Mohid S.
    El-Khouly, Fatima
    Toumpanakis, Christos
    Meyer, Tim
    Caplin, Martyn
    Tu Vinh Luong
    GASTROENTEROLOGY, 2011, 140 (05) : S116 - S116
  • [50] Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer
    Heusinger, Katharina
    Jud, Sebastian M.
    Haeberle, Lothar
    Hack, Carolin C.
    Fasching, Peter A.
    Meier-Meitinger, Martina
    Lux, Michael P.
    Hagenbeck, Carsten
    Loehberg, Christian R.
    Wittenberg, Thomas
    Rauh, Claudia
    Wagner, Florian
    Uder, Michael
    Hartmann, Arndt
    Schulz-Wendtland, Ruediger
    Beckmann, Matthias W.
    Wachter, David L.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (03) : 885 - 892